Tianjin Huanhu Hospital

This study tests whether giving a protein called albumin directly into the artery, right after a stroke clot is removed, can reduce brain damage. Sixty adults with large-vessel stroke will be randomly assigned to get either standard care alone or standard care plus albumin. The m…

This early-stage trial will test a new treatment called QT-019C, which uses specially engineered immune cells (CAR T-cells) to target and attack faulty immune cells in people with relapsed or refractory neurological autoimmune diseases like multiple sclerosis, neuromyelitis optic…

This Phase 2 trial tests whether giving human albumin directly into the artery supplying the brain, right after a clot is removed, can improve recovery in people with severe stroke. About 306 participants will be randomly assigned to receive either standard clot removal alone or …